Document Detail

Dual dopamine agonist treatment in Parkinson's disease.
MedLine Citation:
PMID:  12883924     Owner:  NLM     Status:  MEDLINE    
We studied the effectiveness of cabergoline as an adjunct in patients with early Parkinson's disease receiving another dopamine agonist (pramipexole or ropinirole), at the maximal permitted dose. The study enrolled 47 patients: 35 had motor fluctuations and were receiving a dopamine agonist with levodopa; and 12, without motor fluctuations, were receiving a dopamine agonist without levodopa. These medications had in all cases failed to achieve adequate symptom control. In the 35 patients with motor fluctuations, when cabergoline was added to therapy, the time spent in the OFF period decreased by 65.6% (from 3.14+/-1.11 to 1.08+/-1.07 hours p<0.0001); and the Unified Parkinson's Disease Rating Scale (UPDRS) motor score decreased by 19.24% (from 41.68+/-12.6 to 33.66+/-10.22; (p<0.0001) during the OFF condition, and by 7.11% (from 17.01+/-6.63 to 15.8+/-7.22; p<0.001) during the ON condition. Nocturnal akinesia improved in all the patients except one. In the 12 patients without motor fluctuations, when cabergoline was added, the UPDRS score improved by 34.4% (from 23.5+/-5.3 to 15.5+/-4.7). This open study shows that dual dopamine agonist therapy can be useful in the symptomatic treatment of patients with early or more advanced Parkinson's disease receiving therapy with or without levodopa.
Fabrizio Stocchi; Laura Vacca; Alfredo Berardelli; Marco Onofrj; Mario Manfredi; Stefano Ruggieri
Related Documents :
22912554 - Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerat...
22419774 - Coexistence of hypothyroidism with inflammatory arthritis is associated with cardiovasc...
15279064 - Videofluorographic observations on swallowing in patients with dysphagia due to neurode...
17179514 - Predictors of survival and technique success after reinsertion of peritoneal dialysis c...
24677944 - A18: risk factors for symptomatic avascular necrosis in childhood-onset systemic lupus ...
20642954 - Allergic broncho-pulmonary aspergillosis presenting as flitting opacities on chest radi...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of neurology     Volume:  250     ISSN:  0340-5354     ISO Abbreviation:  J. Neurol.     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-07-28     Completed Date:  2003-09-16     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  0423161     Medline TA:  J Neurol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  822-6     Citation Subset:  IM    
Department of Neurological Sciences, IRCCS NEUROMED POZZILLI (IS), Viale dell'Università 30, 00185, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dopamine Agonists / therapeutic use*
Drug Therapy, Combination
Middle Aged
Parkinson Disease / drug therapy*
Prospective Studies
Single-Blind Method
Reg. No./Substance:
0/Dopamine Agonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective stud...
Next Document:  Metabolic correlates of behavioral and affective disturbances in frontal lobe pathologies.